Bioavailability of oestradiol from the Alora (0.1 mg/day) oestradiol matrix transdermal delivery system compared with Estraderm (0.1 mg/day).

Autor: Bowen, Angela J., John, V. A., Ramirez, Maria E., Good, W. R.
Předmět:
Zdroj: Journal of Obstetrics & Gynaecology; Nov98, Vol. 18 Issue 6, p575, 6p, 1 Diagram, 3 Graphs
Abstrakt: Compares the bioavailability of oestradiol administered by an oestradiol matrix transdermal delivery system, Alora 0.1 milligram a day, with Estraderm. Discussion on oestrogen replacement therapy (ERT); Design and methodology of the study; Results of the study; Discussion and conclusions.
Databáze: Complementary Index